300 related articles for article (PubMed ID: 18031245)
1. HPV: from infection to cancer.
Stanley MA; Pett MR; Coleman N
Biochem Soc Trans; 2007 Dec; 35(Pt 6):1456-60. PubMed ID: 18031245
[TBL] [Abstract][Full Text] [Related]
2. Selection of cervical keratinocytes containing integrated HPV16 associates with episome loss and an endogenous antiviral response.
Pett MR; Herdman MT; Palmer RD; Yeo GS; Shivji MK; Stanley MA; Coleman N
Proc Natl Acad Sci U S A; 2006 Mar; 103(10):3822-7. PubMed ID: 16505361
[TBL] [Abstract][Full Text] [Related]
3. Interferon-beta treatment of cervical keratinocytes naturally infected with human papillomavirus 16 episomes promotes rapid reduction in episome numbers and emergence of latent integrants.
Herdman MT; Pett MR; Roberts I; Alazawi WO; Teschendorff AE; Zhang XY; Stanley MA; Coleman N
Carcinogenesis; 2006 Nov; 27(11):2341-53. PubMed ID: 16973673
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic silencing of interferon-kappa in human papillomavirus type 16-positive cells.
Rincon-Orozco B; Halec G; Rosenberger S; Muschik D; Nindl I; Bachmann A; Ritter TM; Dondog B; Ly R; Bosch FX; Zawatzky R; Rösl F
Cancer Res; 2009 Nov; 69(22):8718-25. PubMed ID: 19887612
[TBL] [Abstract][Full Text] [Related]
5. Induction of tumor-specific CD4+ and CD8+ T-cell immunity in cervical cancer patients by a human papillomavirus type 16 E6 and E7 long peptides vaccine.
Welters MJ; Kenter GG; Piersma SJ; Vloon AP; Löwik MJ; Berends-van der Meer DM; Drijfhout JW; Valentijn AR; Wafelman AR; Oostendorp J; Fleuren GJ; Offringa R; Melief CJ; van der Burg SH
Clin Cancer Res; 2008 Jan; 14(1):178-87. PubMed ID: 18172269
[TBL] [Abstract][Full Text] [Related]
6. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells.
Sima N; Wang S; Wang W; Kong D; Xu Q; Tian X; Luo A; Zhou J; Xu G; Meng L; Lu Y; Ma D
Gynecol Oncol; 2007 Aug; 106(2):299-304. PubMed ID: 17586029
[TBL] [Abstract][Full Text] [Related]
7. High-risk human papillomavirus E7 expression reduces cell-surface MHC class I molecules and increases susceptibility to natural killer cells.
Bottley G; Watherston OG; Hiew YL; Norrild B; Cook GP; Blair GE
Oncogene; 2008 Mar; 27(12):1794-9. PubMed ID: 17828295
[TBL] [Abstract][Full Text] [Related]
8. Silencing of E7 oncogene restores functional E-cadherin expression in human papillomavirus 16-transformed keratinocytes.
Caberg JH; Hubert PM; Begon DY; Herfs MF; Roncarati PJ; Boniver JJ; Delvenne PO
Carcinogenesis; 2008 Jul; 29(7):1441-7. PubMed ID: 18566017
[TBL] [Abstract][Full Text] [Related]
9. Frequent display of human papillomavirus type 16 E6-specific memory t-Helper cells in the healthy population as witness of previous viral encounter.
Welters MJ; de Jong A; van den Eeden SJ; van der Hulst JM; Kwappenberg KM; Hassane S; Franken KL; Drijfhout JW; Fleuren GJ; Kenter G; Melief CJ; Offringa R; van der Burg SH
Cancer Res; 2003 Feb; 63(3):636-41. PubMed ID: 12566307
[TBL] [Abstract][Full Text] [Related]
10. HPV induced cervical carcinogenesis: molecular basis and vaccine development.
Kaufmann AM; Backsch C; Schneider A; Dürst M
Zentralbl Gynakol; 2002 Nov; 124(11):511-24. PubMed ID: 12796844
[TBL] [Abstract][Full Text] [Related]
11. The relationship between cytokines and HPV-16, HPV-16 E6, E7, and high-risk HPV viral load in the uterine cervix.
Song SH; Lee JK; Seok OS; Saw HS
Gynecol Oncol; 2007 Mar; 104(3):732-8. PubMed ID: 17188341
[TBL] [Abstract][Full Text] [Related]
12. Type-dependent integration frequency of human papillomavirus genomes in cervical lesions.
Vinokurova S; Wentzensen N; Kraus I; Klaes R; Driesch C; Melsheimer P; Kisseljov F; Dürst M; Schneider A; von Knebel Doeberitz M
Cancer Res; 2008 Jan; 68(1):307-13. PubMed ID: 18172324
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms of cervical carcinogenesis by high-risk human papillomaviruses: novel functions of E6 and E7 oncoproteins.
Yugawa T; Kiyono T
Rev Med Virol; 2009 Mar; 19(2):97-113. PubMed ID: 19156753
[TBL] [Abstract][Full Text] [Related]
14. [Expression, purification, and serum antibody detection of HPV16 E6 in cervical cancer patients].
Gao YE; Guo JZ; Zhang J; Song TB; Yan XJ
Ai Zheng; 2006 Nov; 25(11):1374-9. PubMed ID: 17094904
[TBL] [Abstract][Full Text] [Related]
15. Phase I immunotherapeutic trial with long peptides spanning the E6 and E7 sequences of high-risk human papillomavirus 16 in end-stage cervical cancer patients shows low toxicity and robust immunogenicity.
Kenter GG; Welters MJ; Valentijn AR; Lowik MJ; Berends-van der Meer DM; Vloon AP; Drijfhout JW; Wafelman AR; Oostendorp J; Fleuren GJ; Offringa R; van der Burg SH; Melief CJ
Clin Cancer Res; 2008 Jan; 14(1):169-77. PubMed ID: 18172268
[TBL] [Abstract][Full Text] [Related]
16. Optimal induction of HPV DNA vaccine-induced CD8+ T cell responses and therapeutic antitumor effect by antigen engineering and electroporation.
Seo SH; Jin HT; Park SH; Youn JI; Sung YC
Vaccine; 2009 Sep; 27(42):5906-12. PubMed ID: 19651174
[TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase-2 transcription is regulated by human papillomavirus 16 E6 and E7 oncoproteins: evidence of a corepressor/coactivator exchange.
Subbaramaiah K; Dannenberg AJ
Cancer Res; 2007 Apr; 67(8):3976-85. PubMed ID: 17440114
[TBL] [Abstract][Full Text] [Related]
18. Changes in cervical keratinocyte gene expression associated with integration of human papillomavirus 16.
Alazawi W; Pett M; Arch B; Scott L; Freeman T; Stanley MA; Coleman N
Cancer Res; 2002 Dec; 62(23):6959-65. PubMed ID: 12460913
[TBL] [Abstract][Full Text] [Related]
19. [Expression purification and clinical application of high-risk HPV16 E4 gene].
Gao YE; Hui H; Zhang J; Fan JB; Yan XJ
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Aug; 33(8):676-81. PubMed ID: 18772505
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus 16 E6, L1, L2 and E2 gene variants in cervical lesion progression.
Lee K; Magalhaes I; Clavel C; Briolat J; Birembaut P; Tommasino M; Zehbe I
Virus Res; 2008 Jan; 131(1):106-10. PubMed ID: 17869365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
